Table 1.
Cortisol reactivity to a conflict resolution task by drug condition and level of intimate partner violence (IPV)
| Model | Men | Women | ||||
|---|---|---|---|---|---|---|
| Psychological Victimization | B | SE | p | B | SE | p |
| Intercept | 0.10 | 0.03 | 0.000 | 0.04 | 0.05 | 0.357 |
| Time | −0.02 | 0.01 | 0.018 | −0.01 | 0.01 | 0.479 |
| Time2 | 0.00 | 0.00 | 0.188 | 0.00 | 0.00 | 0.714 |
| Baseline Cortisol | 0.54 | 0.05 | 0.000 | 0.79 | 0.10 | 0.000 |
| Drug Condition (Placebo v. OT) | −0.03 | 0.03 | 0.314 | −0.05 | 0.05 | 0.296 |
| Time × Drug Condition | 0.02 | 0.01 | 0.125 | −0.02 | 0.01 | 0.127 |
| Time2 × Drug Condition | 0.00 | 0.00 | 0.411 | 0.00 | 0.00 | 0.148 |
| IPV | 0.00 | 0.00 | 0.220 | 0.00 | 0.00 | 0.676 |
| Drug Condition × IPV | 0.00 | 0.00 | 0.465 | 0.00 | 0.00 | 0.749 |
| Time × IPV | 0.00 | 0.00 | 0.607 | 0.00 | 0.00 | 0.873 |
| Time2 × IPV | 0.00 | 0.00 | 0.591 | 0.00 | 0.00 | 0.775 |
| Time × Drug Condition × IPV | 0.00 | 0.00 | 0.224 | 0.00 | 0.00 | 0.671 |
| Time2 × Drug Condition × IPV | 0.00 | 0.00 | 0.558 | 0.00 | 0.00 | 0.900 |
| Psychological Perpetration | ||||||
| Intercept | 0.09 | 0.03 | 0.001 | 0.04 | 0.05 | 0.422 |
| Time | −0.02 | 0.01 | 0.018 | −0.01 | 0.01 | 0.254 |
| Time2 | 0.00 | 0.00 | 0.149 | 0.00 | 0.00 | 0.797 |
| Baseline Cortisol | 0.55 | 0.05 | 0.000 | 0.79 | 0.10 | 0.000 |
| Drug Condition (Placebo v. OT) | −0.02 | 0.03 | 0.514 | −0.04 | 0.05 | 0.386 |
| Time × Drug Condition | 0.02 | 0.01 | 0.201 | −0.02 | 0.01 | 0.206 |
| Time2 × Drug Condition | 0.00 | 0.00 | 0.408 | 0.00 | 0.00 | 0.162 |
| IPV | 0.00 | 0.00 | 0.704 | 0.00 | 0.00 | 0.804 |
| Drug Condition × IPV | 0.00 | 0.00 | 0.952 | 0.00 | 0.00 | 0.899 |
| Time × IPV | 0.00 | 0.00 | 0.591 | 0.00 | 0.00 | 0.456 |
| Time2 × IPV | 0.00 | 0.00 | 0.693 | 0.00 | 0.00 | 0.880 |
| Time × Drug Condition × IPV | 0.00 | 0.00 | 0.192 | 0.00 | 0.00 | 0.477 |
| Time2 × Drug Condition × IPV | 0.00 | 0.00 | 0.374 | 0.00 | 0.00 | 0.907 |
| Physical Victimization | ||||||
| Intercept | 0.08 | 0.02 | 0.001 | 0.03 | 0.03 | 0.392 |
| Time | −0.02 | 0.01 | 0.004 | 0.00 | 0.01 | 0.658 |
| Time2 | 0.00 | 0.00 | 0.037 | 0.00 | 0.00 | 0.843 |
| Baseline Cortisol | 0.54 | 0.05 | 0.000 | 0.80 | 0.10 | 0.000 |
| Drug Condition (Placebo v. OT) | −0.01 | 0.02 | 0.757 | −0.04 | 0.03 | 0.289 |
| Time × Drug Condition | 0.01 | 0.01 | 0.477 | −0.02 | 0.01 | 0.014 |
| Time2 × Drug Condition | 0.00 | 0.00 | 0.562 | 0.00 | 0.00 | 0.106 |
| IPV | 0.00 | 0.00 | 0.322 | 0.00 | 0.00 | 0.899 |
| Drug Condition × IPV | 0.00 | 0.00 | 0.313 | 0.00 | 0.00 | 0.992 |
| Time × IPV | 0.00 | 0.00 | 0.499 | 0.00 | 0.00 | 0.345 |
| Time2 × IPV | 0.00 | 0.00 | 0.950 | 0.00 | 0.00 | 0.976 |
| Time × Drug Condition × IPV | 0.00 | 0.00 | 0.872 | 0.00 | 0.00 | 0.586 |
| Time2 × Drug Condition × IPV | 0.00 | 0.00 | 0.734 | 0.00 | 0.00 | 0.787 |
| Physical Perpetration | ||||||
| Intercept | 0.09 | 0.02 | 0.000 | 0.04 | 0.03 | 0.281 |
| Time | −0.02 | 0.01 | 0.001 | 0.00 | 0.01 | 0.607 |
| Time2 | 0.00 | 0.00 | 0.046 | 0.00 | 0.00 | 0.363 |
| Baseline Cortisol | 0.54 | 0.05 | 0.000 | 0.81 | 0.09 | 0.000 |
| Drug Condition (Placebo v. OT) | −0.02 | 0.02 | 0.356 | −0.05 | 0.04 | 0.211 |
| Time × Drug Condition | 0.00 | 0.01 | 0.893 | −0.03 | 0.01 | 0.003 |
| Time2 × Drug Condition | 0.00 | 0.00 | 0.967 | 0.00 | 0.00 | 0.046 |
| IPV | 0.00 | 0.00 | 0.945 | 0.00 | 0.00 | 0.418 |
| Drug Condition × IPV | 0.00 | 0.00 | 0.829 | 0.00 | 0.00 | 0.544 |
| Time × IPV | 0.00 | 0.00 | 0.926 | 0.00 | 0.00 | 0.023 |
| Time2 × IPV | 0.00 | 0.00 | 0.939 | 0.00 | 0.00 | 0.206 |
| Time × Drug Condition × IPV | 0.00 | 0.00 | 0.473 | 0.00 | 0.00 | 0.075 |
| Time2 × Drug Condition × IPV | 0.00 | 0.00 | 0.800 | 0.00 | 0.00 | 0.357 |
Note. Statistically significant effects at p < 0.05 are bolded. Effects that trend toward significance at p < 0.10 are bolded and italicized.